DOCOMO and Ericsson Succeed in World's First Trial to Achieve Cumulative 20Gbps with Two Simultaneously Connected Mobile Devices in 5G Outdoor Trial
NTT DOCOMO, INC. and Ericsson (NASDAQ:ERIC) announced today that in a joint 5G technologies trial, the companies achieved a cumulative 20Gbps of data throughput in an outdoor environment using the 15GHz frequency band with two simultaneously connected mobile devices of a downlink bit rate of over 10Gbps each, on February 21. The data speed satisfies one of the key requirements for future 5G commercial services.
The companies also succeeded in a separate trial on February 21, data throughput exceeding 10Gbps at a distance of approximately 70 meters from the base station, or about 7 times farther than the distance achieved in a past trial. Moreover, the data transmission exceeding 9Gbps at a distance of about 120 meters from the base station was also succeeded.
5G will use high-frequency bands, which are inclined to experience attenuation in speed and capacity as they travel over long distances.
The trial, which took place at the DOCOMO R&D Center in the city of Yokosuka, Japan, utilized a specification defined jointly by DOCOMO and Ericsson, and an Ericsson 5G Radio Prototype and user devices, in place of mobile phones, from Ericsson.
The data speeds were achieved thanks to multi-beam multiple-input multiple-output (MIMO) technology, which increases data speeds by multiplexing radio waves simultaneously. Also, by utilizing a beam-forming technique that incorporates beams, each one consisting of 64 antenna elements to converge highly directional long-distance signals on a single target, the cumulative 20Gbps throughput was successfully transmitted.
For further information, please contact:
Public Relations Department
Ericsson Corporate Communications
Phone: +46 10 719 69 92
Ericsson Investor Relations
Phone: +46 10 719 00 00
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skrive dig op her og du vil løbende modtage pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
BOEHRINGER-INGELHEIM11.12.2017 14:02 | pressemeddelelse
Boehringer Ingelheim Marks Great Progress in Immuno-oncology Research Partnerships in 2017
NY-VALENCE-GROUP11.12.2017 13:49 | pressemeddelelse
Valence Advises SK Capital on Its Acquisition of ICL’s Fire Safety and Oil Additives Businesses
SMITH-&-NEPHEW11.12.2017 11:20 | pressemeddelelse
Smith & Nephew Announce European Launch of Handheld Imaging Technology Heralding a New Era of Evidence-Based Decision Making in Wound Care
UAE-FNC11.12.2017 10:43 | pressemeddelelse
Dr Amal Al Qubaisi Wins Parliamentarian Excellence Award as Best President of Arab Parliament
GA-CELLTRION-HEALTHCARE11.12.2017 09:02 | pressemeddelelse
Top UK university hospital unveils data that support the use of rapid infusion for Truxima® (CT-P10, biosimilar rituximab) in patients with advanced-stage follicular lymphoma
DIMOCO-EUROPE11.12.2017 09:02 | pressemeddelelse
Financial Market Regulator Grants EU Payment License to DIMOCO Payment Services
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum